Hospital
Scripps Health
Scripps Health was paid $9.79M by Medicaid between Jan 2018 and Nov 2024, across 125 billing codes. Its largest line is 99499, — 23% of everything it billed.
33Billing provider infoSCRIPPS HEALTH
LA JOLLA, CA 92037
LA JOLLA, CA 92037
33aNPI1841277704assigned 12/30/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.79M
24GClaims219,821
24DCodes billed125
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#182 of 410
Median peer was paid$6.90M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 40,354 | $1.28M | |
| 2019 | 36,712 | $1.56M | |
| 2020 | 23,694 | $932K | |
| 2021 | 32,732 | $1.51M | |
| 2022 | 38,778 | $2.06M | |
| 2023 | 32,245 | $1.74M | |
| 2024incomplete | 15,306 | $716K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99499 | 23% | 8,066 | 6,120 | $2.25M | |
| 0450 | Emergency room services | 14% | 18,509 | 16,588 | $1.33M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.2% | 11,235 | 10,834 | $896K |
| 0762 | 7.2% | 440 | 420 | $702K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.2% | 7,191 | 6,516 | $508K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.0% | 1,455 | 1,348 | $388K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.9% | 2,618 | 2,450 | $381K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2.8% | 1,195 | 1,142 | $276K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.6% | 8,748 | 8,012 | $258K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.2% | 4,567 | 3,840 | $212K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.0% | 2,006 | 1,865 | $196K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2.0% | 1,377 | 1,271 | $194K |
113 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 22,537 | $188K |
| 80053 | Comprehensive metabolic panel | 1.8% | 12,759 | $174K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.3% | 823 | $129K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.0% | 1,571 | $99K |
| 0710 | 1.0% | 940 | $99K | |
| J3490 | Unclassified drugs | 1.0% | 27,248 | $99K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,122 | $96K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 591 | $82K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,430 | $77K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,250 | $74K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,294 | $72K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,581 | $66K |
| Z7502 | <1% | 1,710 | $62K | |
| A4217 | Sterile water/saline, 500 ml | <1% | 4,515 | $60K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,949 | $52K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 539 | $48K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 5,461 | $47K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,423 | $44K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,574 | $43K |
| 0270 | <1% | 2,730 | $35K | |
| 0272 | <1% | 1,413 | $30K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,961 | $29K |
| 84484 | <1% | 3,322 | $29K | |
| 83690 | <1% | 3,639 | $27K | |
| 0360 | <1% | 350 | $27K | |
| 99199 | Unlisted special service, procedure or report | <1% | 403 | $26K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 338 | $25K |
| 96379 | <1% | 1,433 | $24K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 13 | $23K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,186 | $20K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 75 | $20K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 324 | $17K |
| 83880 | <1% | 658 | $13K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 398 | $11K |
| 83735 | <1% | 1,986 | $11K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 407 | $10K |
| J2704 | Injection, propofol, 10 mg | <1% | 904 | $9K |
| 0259 | <1% | 1,658 | $8K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,380 | $8K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,707 | $8K |
| 83605 | <1% | 956 | $8K | |
| 81001 | <1% | 2,472 | $8K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 878 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 912 | $7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 606 | $7K |
| 0250 | <1% | 282 | $7K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 318 | $6K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,717 | $6K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 27 | $6K |
| 70496 | <1% | 24 | $6K | |
| 70498 | <1% | 25 | $6K | |
| 80306 | <1% | 190 | $5K | |
| 73562 | <1% | 147 | $5K | |
| 85610 | <1% | 1,891 | $5K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 146 | $5K |
| 84703 | <1% | 717 | $5K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 490 | $4K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 297 | $4K |
| 85730 | <1% | 994 | $4K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 91 | $3K |
| Z7610 | <1% | 302 | $3K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 376 | $3K |
| 73030 | <1% | 82 | $3K | |
| G0378 | Hospital observation service, per hour | <1% | 14 | $3K |
| 81003 | <1% | 654 | $3K | |
| 93971 | <1% | 27 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 12 | $2K |
| 87040 | <1% | 187 | $2K | |
| 0750 | <1% | 14 | $2K | |
| 70486 | <1% | 12 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 134 | $2K |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 217 | $2K |
| 71250 | <1% | 12 | $2K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 151 | $2K |
| 76641 | <1% | 28 | $2K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 79 | $2K |
| 85379 | <1% | 168 | $2K | |
| 86900 | <1% | 215 | $2K | |
| 77066 | Tomosynthesis, mammo | <1% | 12 | $2K |
| 73610 | <1% | 44 | $1K | |
| 86850 | <1% | 100 | $1K | |
| 86901 | <1% | 203 | $1K | |
| 0370 | <1% | 28 | $925.60 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 116 | $858.63 |
| 72100 | <1% | 26 | $800.80 | |
| 86140 | <1% | 142 | $791.02 | |
| V2632 | Posterior chamber intraocular lens | <1% | 40 | $768.01 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 16 | $758.94 |
| 88304 | <1% | 65 | $745.49 | |
| 71010 | <1% | 42 | $743.82 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 71 | $707.00 |
| 81025 | <1% | 56 | $706.33 | |
| 71020 | <1% | 23 | $685.56 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 164 | $652.14 |
| 87186 | <1% | 98 | $628.04 | |
| 73630 | <1% | 15 | $618.81 | |
| 87077 | <1% | 130 | $603.20 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 12 | $559.35 |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 43 | $506.35 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $452.14 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 14 | $451.43 |
| C1769 | Guide wire | <1% | 28 | $424.02 |
| 73130 | <1% | 12 | $391.03 | |
| 84145 | <1% | 14 | $330.41 | |
| 99070 | <1% | 170 | $304.86 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 19 | $206.82 |
| 85652 | <1% | 65 | $175.14 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 45 | $129.89 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 32 | $54.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 48 | $51.59 |
| 87205 | <1% | 16 | $45.68 | |
| 80061 | Lipid panel | 0% | 12 | $0.00 |
| 0258 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTANDE, BRETT (EVP CFO)
Parent organizationSCRIPPS HEALTH
| Provider | Location | Paid |
|---|---|---|
| Scripps Health | San Diego, CA | $64.23M |
| Scripps Health | Encinitas, CA | $11.95M |
| Scripps Health | La Jolla, CA | $502K |
| Scripps Health | La Jolla, CA | $57K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.